| Sandoz Pharmaceuticals AG - Naropin 7.5 mg/ml, Injektionslösung |
| 54015 | | 02 | | Naropin 7.5 mg/ml | | Injektionslösung | | N01BB09 | | Ropivacaine | | 27.02.1997 | | |
|
| Composition |
| ropivacaini hydrochloridum 7.5 mg corresp. ropivacainum 6.6 mg, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium max. 3.2 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
|---|
| Ropivacaine Hydrochloride | 7.5 mg/ml correspond Ropivacaine 6.6 mg/ml |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Sodium Chloride | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 5 x 10 ml | PR | PR | B | | No | | 004 | 5 x 20 ml | PR | PR | B | | No |
|
